| Name (Department) |
P&F Funding Dates | Topic |
| Bolger, Graeme (Medicine) | 2007-2009 | Activation of CFTR by compartmental phosphodiesterase |
| Fanucchi, Michelle (Public Health) | 2007-2009 | Ozone exposure in CF mouse lung |
| Harris, William Thomas (Pediatrics) | 2009-2011 | TGF-β in CF: Activity and therapeutic possibilities |
| Maheshwari, Akhil (Pediatrics) | 2009-2011 | Intestinal Mucosal inflammation in cystic fibrosis |
| Barnes, Stephen | 2011-2013 | Post-translational modifications (PTMs) of CFTR |
| Piazza, Gary (South Alabama) | 2011-2013 | Spectral Domain Optical Coherence Tomography for the Functional Characterization of Ion Transport Modulators |
| Jackson, Patricia (Medicine) | 2011-2013 | Modulation of small matrikines by reactive aldehydes in CF |
| Kong, Michelle | 2013-2015 | Matrix metalloproteinase-9 facilitated RSV infection in cystic fibrosis |
| Kesterson, Robert | 2013-2015 | Establishing genetically modified rat models of CFTR function |
| Bernard, Karen (Medicine) | 2013-2015 | Clusterin control of lung matrix remodeling |
| Solomon, George (Medicine) | 2015-2017 | Nasal Epithelial Cells as an Outcome Tool for Individualized CFTR Therapeutics |
| Wells, J. Michael (Medicine) | 2015-2017 | CFTR function and pulmonary hypertension in cystic fibrosis |
| Cho, Do (Otolaryngology) | 2017-2019 | Controlled delivery of Ciprofloxacin and Ivacaftor via Sinus Stent in Pseudomonas Rhinosinusitis |
| Du, Ming (Biochemistry) | 2017-2019 | The effect of readthrough drugs and NMD inhibitors on normal stop codons |
| Zhao, Rui (Biochemistry) | 2017-2019 | Using human iPSCs to model cystic fibrosis and to generate human lung tissues |
| Krick, Stefanie (Medicine) | 2019-2021 | Mucus Viscoelasticity is Mediated by Oxidase Enzymes through Oxidative Protein Crosslinking |
| Barnes, Jarrod (Medicine) | 2019-2021 | Impaired Mucin Glycosylation regulates Mucus Transport, Viscosity, and Host Defense in Cystic Fibrosis |
| Genschmer, Kristopher (Medicine) | 2021-2023 | Neutrophil-derived proteolytic exosomes in CF lung disease |
| Marqez-Lago, Tatiana (Genetics) |
2021-2023 | Multi-omics determination of lung microbiota functional networks according to CFTR modulator use |
| Kiedrowski, Megan (Medicine) | 2023-2024, 2024-2026** | Detection of Bacterial Infections in Cystic Fibrosis by Noninvasive Imaging |
| Margaroli Bell, Camilla (Pathology) | 2023-2024, 2024-2026** |
Characterization of adaptive immune responses to non-turberculous mycobacteria infection in CF |
**Proposed for the next cycle of RDP funding